Indeed, in HER2+/ BL-ΔP mice, tumor latency was reduced, whereas breast cancer frequency was increased and tumors showed a more aggressive phenotype (higher mitotic index, multilobular appearance, cancer cell embolization in vessels, and EMT characteristics). This evidence concerns the gene ERBB2 and breast carcinoma.